Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Working Capital/Sales

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   Working Capital/Sales(x) 1.121.080.991.026.37

What is the latest Working Capital/Sales ratio of NATH BIOGENES (INDIA) ?

The latest Working Capital/Sales ratio of NATH BIOGENES (INDIA) is 1.12 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.12
Mar20241.08
Mar20230.99
Mar20221.02
Mar20136.37

How is Working Capital/Sales of NATH BIOGENES (INDIA) Trending?

Years Working Capital/Sales % Change
Mar2025 1.12
3.70
Mar2024 1.08
9.09
Mar2023 0.99
-2.94
Mar2022 1.02
-83.99
Mar2013 6.37 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Working Capital/Sales ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹297.3 Cr -3.2% -8.7% -13.4% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,824.8 Cr -3.9% -9.4% -25.6% Stock Analytics
KAVERI SEED COMPANY ₹5,041.0 Cr -4.7% -8.3% 21.8% Stock Analytics
VENKYS (INDIA) ₹1,885.0 Cr -0.7% -7.8% -20.8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,118.4 Cr -2.8% -12.2% -21.8% Stock Analytics
INDO US BIOTECH ₹296.3 Cr 9% -2.9% -55.9% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-3.2%

-8.7%

-13.4%

SENSEX

0.1%

1.1%

8.4%


You may also like the below Video Courses